Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Baert

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Gastroenterology|September 1, 1996
Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristicsM Peeters, H Nevens, F Baert, et al.
Acta Gastro-Enterologica Belgica|February 17, 2025
Switching intravenous to subcutaneous infliximab was safe and successful during 1-year follow up in Ulcerative Colitis and Crohn patients - a Belgian single center experienceL Cornelis, E De Jonckere, J Bossuyt, et al.
Acta Gastro-Enterologica Belgica|November 23, 2013
Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literatureD Dooremont, J Decaestecker, D De Wulf, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2000
Crohn's disease and intestinal endometriosis: an intriguing co-existenceM Craninx, G D'Haens, K Cokelaere, et al.
European Radiology|February 11, 2005
CT colonography with fecal tagging after incomplete colonoscopyS Gryspeerdt, P Lefere, M Herman, et al.
Gastroenterology|September 1, 1997
Clustering of increased small intestinal permeability in families with Crohn's diseaseM Peeters, B Geypens, D Claus, et al.
Gut|August 14, 1999
Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitisF Baert, K Wouters, G D'Haens, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2014
Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitisF Baert, N Vande Casteele, S Tops, et al.
Acta Gastro-Enterologica Belgica|July 8, 2026
Multi-stakeholder Delphi consensus on future care for inflammatory bowel disease in BelgiumT Taelman, N Deprez, J King, et al.
Gastroenterology|April 30, 1999
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trialG D'haens, S Van Deventer, R Van Hogezand, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Gastroenterology|September 1, 1996
Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristicsM Peeters, H Nevens, F Baert, et al.
Acta Gastro-Enterologica Belgica|February 17, 2025
Switching intravenous to subcutaneous infliximab was safe and successful during 1-year follow up in Ulcerative Colitis and Crohn patients - a Belgian single center experienceL Cornelis, E De Jonckere, J Bossuyt, et al.
Acta Gastro-Enterologica Belgica|November 23, 2013
Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literatureD Dooremont, J Decaestecker, D De Wulf, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2000
Crohn's disease and intestinal endometriosis: an intriguing co-existenceM Craninx, G D'Haens, K Cokelaere, et al.
European Radiology|February 11, 2005
CT colonography with fecal tagging after incomplete colonoscopyS Gryspeerdt, P Lefere, M Herman, et al.
Gastroenterology|September 1, 1997
Clustering of increased small intestinal permeability in families with Crohn's diseaseM Peeters, B Geypens, D Claus, et al.
Gut|August 14, 1999
Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitisF Baert, K Wouters, G D'Haens, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2014
Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitisF Baert, N Vande Casteele, S Tops, et al.
Acta Gastro-Enterologica Belgica|July 8, 2026
Multi-stakeholder Delphi consensus on future care for inflammatory bowel disease in BelgiumT Taelman, N Deprez, J King, et al.
Gastroenterology|April 30, 1999
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trialG D'haens, S Van Deventer, R Van Hogezand, et al.
Pageof 6